Development and internal validation of a nomogram for predicting in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease.
Аннотация
BACKGROUND
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD)-related in-hospital mortality poses a significant clinical challenge. Existing prognostic tools-including the DECAF (Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation) score, which requires eosinophil count and chest radiography, and the BAP-65 (Blood urea nitrogen, Altered mental status, Pulse rate, and age ≥65 years) score, which incorporates blood urea nitrogen measurement-depend on haematological or radiological investigations that may not be immediately available at admission. This study aims to develop a nomogram based on clinical admission variables and arterial blood gas analysis for early risk stratization in patients with AECOPD.
METHODS
This single-centre retrospective cohort study enrolled consecutive patients hospitalised for AECOPD between December 2016 and December 2018. Eligible patients had spirometry-confirmed COPD [post-bronchodilator forced expiratory volume in one second/forced vital capacity (FEV1/FVC) <0.70] admitted for an acute exacerbation, with a hospital stay of at least 24 hours; those with severe concurrent conditions or substantial missing data were excluded. Univariate and multivariable logistic regression identified independent admission-level predictors of in-hospital mortality. A nomogram was constructed and internally validated using 1,000-iteration bootstrap resampling.
RESULTS
Among 1,719 patients [75.6% male; median age 77.0 years, interquartile range (IQR): 69.0-84.0], 188 (10.9%) died during hospitalisation. Multivariable logistic regression (n=1,570) identified six independent predictors: older age [odds ratio (OR) =1.03, 95% confidence interval (CI): 1.02-1.05], higher modified Medical Research Council dyspnoea scale (mMRC) grade (OR =1.28, 95% CI: 1.05-1.56), lower peripheral oxygen saturation (SpO2) (OR =0.96, 95% CI: 0.94-0.99), malnutrition (OR =1.81, 95% CI: 1.06-2.97), elevated arterial partial pressure of carbon dioxide (PaCO2) (OR =1.01, 95% CI: 1.00-1.02), and hypertension (OR =0.54, 95% CI: 0.35-0.81, inversely associated). The nomogram demonstrated moderate discrimination [apparent area under the curve (AUC) =0.678, 95% CI: 0.633-0.722; bootstrap-corrected C-statistic =0.665, optimism =0.012], good calibration (Hosmer-Lemeshow P>0.99), and net clinical benefit across threshold probabilities of 2-49%.
CONCLUSIONS
This internally validated nomogram integrates five clinical variables assessable without laboratory testing (age, mMRC grade, SpO2, nutritional status, and hypertension history) with admission PaCO2-a routine investigation in AECOPD-to provide immediate, individualised prediction of in-hospital mortality. The model demonstrated moderate discrimination (bootstrap-corrected C-statistic: 0.665), good calibration, and net clinical benefit across a broad range of threshold probabilities, requiring fewer investigations than existing tools such as DECAF and BAP-65. Prospective external validation in independent multicentre cohorts is warranted before broader clinical implementation.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.